Igenomix

Paterna, Spain Founded: 2009 • Age: 17 yrs Acquired By Vitrolife
Reproductive genetic testing services are provided by the medical laboratory.

About Igenomix

Igenomix is a Healthcare company based in Paterna (Spain) founded in 2009, and was acquired by Vitrolife in July 2021. Reproductive genetic testing services are provided by the medical laboratory. Igenomix has completed 1 acquisition, including Access Genomics. Its website igenomix.com draws about 18 thousand monthly visits. Its Indian entity Igenomix India Private Limited reported revenue of β‚Ή29.93 Cr. Its focus areas include Clinical Laboratory Chains and Diversified.

Company details

Igenomix was founded in 2009 in Paterna, Spain, as a medical testing laboratory. Operations are conducted in the reproductive genetics sector, with genetic tests including PGT-A, ERA, and CGT offered to reproductive health professionals. Diagnosis and treatment of patients are supported through these services. A global presence is maintained, with activities spanning multiple countries.

Operational Areas
Key Metrics
  • Indian entity revenue
    ₹29.93 Cr

    FY 2024 · +19% YoY

  • Indian entity net profit
    ₹1.13 Cr

    FY 2024 · 4% margin

  • Indian entity EBITDA
    ₹1.91 Cr

    FY 2024 · 6% margin

  • Investors
    EQT

    & 3 more

  • Investments & Acquisitions
  • Acquired by
    Vitrolife

    & 2 more

    (Jul 2021)

Apps and channels of Igenomix

its YouTube channel Igenomix, Part of Vitrolife Group has 4.84K subscribers and 30 videos.

Igenomix, Part of Vitrolife Group
YouTube 4.84K subscribers 30 videos Science & Technology
Open channel

Videos from Igenomix

The most watched videos on Igenomix's YouTube channel, Igenomix, Part of Vitrolife Group (4.84K subscribers). Click a video to play it here.

ASRM 2024- Embryo biopsy – best practice
684 views
Interview with T.Barbakadze, Head of Fertility at Georgian American Center for Reproductive Medicine
485 views
ASRM 2024- Unveiling the Impact of the Endometrial Microbiome
482 views
PGT-A Plus Webinar 1: Findings on the incidence of haploidy and triploidy in trophectoderm biopsies
312 views

More on Igenomix, Part of Vitrolife Group .

Funding Insights of Igenomix

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Igenomix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2016Series A–Amadeus Capital
–
Valuation history

4 investors in total: 4 institutional.

Investors in Igenomix

Igenomix has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include EQT, Vitrolife and Amadeus Capital Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Early-stage deep technology investments are made by Amadeus Capital.
amadeuscapital.comLondon, United Kingdom
EQT is recognized as a global investment organization focused on value creation.
1994eqtgroup.comStockholm, Sweden
A European mid-market private equity fund is operated.
charmecapitalpartners.comMilan, Italy
IVF lab equipment and consumables are manufactured and supplied.
1994vitrolife.comGothenburg, Sweden
Premium access

Investor details for Igenomix

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Igenomix India Private Limited (Igenomix)

Igenomix India Private Limited is the primary company behind Igenomix. The board of Igenomix India Private Limited currently have 3 directors; the longest-serving is Deepak Khatter, appointed in 2021. 11 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Deepak Khatter
DIN 07342904
Nominee Director30 Jul 20215 yrs 3 moIgenomix India Private Limited
Ricardo Manuel Capella Soriano
DIN 09637332
Director30 Jun 20224 yrs 4 moIgenomix India Private Limited
Francisco De Paula Ramon Rodriguez Herrera
DIN 06582608
Director30 Jun 20224 yrs 4 moIgenomix India Private Limited

People of Igenomix

35 people are tracked at Igenomix (6 in leadership, 29 in team).

NameRoleGroup
Bronwyn Brophy
CEOLeadership
Rupali Chopra
Laboratory DirectorLeadership
Federico Valdez
VP Global Operations Genetic ServicesLeadership
Jose Ignacio Piñeiro Iglesias
Procurement And Logistics DirectorLeadership
Belén Arnau Colomer
Quality Assurance And Regulatory Affairs DirectorLeadership
Nasser al-Asmar Piñar
Igenomix Academy Scientific DirectorLeadership
Priyanka N. Yadav
Molecular Biologist- Laboratory SpecialistTeam
Inmaculada Campos Galindo
Biólogo. Diagnóstico Genético Preimplantacional.Team
Jose Miravet Valenciano
Technology Office ManagerTeam
Sruthi Warrier
Laboratory ManagerTeam
ِAmr Saeed
Account Manager: Saudi Eastern Province & BahrainTeam
Amit Maurya
Finance ManagerTeam
Julio Martin
Applied Clinical Development, Single-gene Disorders,Team
Javier González Fernández
Scientific ResearcherTeam
Claudia Abellan Orihuela
Genetic Precision Diagnosis SpecialistTeam
Emilio de la Fuente Lucena
Clinical Research Associate / Clinical Trial Assistant / International Regulatory Affairs SpecialistTeam
Alba Velo Fernández
Supervisora De Diagnóstico GenéticoTeam
Jorge Jiménez Almazán
Bioinformatics Department ManagerTeam
Alejandro Luis Zanón Perelló
Operations Excellence Manager &pmoTeam
Alissa Magwood
Business Development & Scientific AdvisorTeam

15 more people are available in the full profile.

Premium access

Complete people profiles for Igenomix

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Igenomix

Figures of Igenomix India Private Limited, the primary company behind Igenomix, for FY 2024. Revenue was ₹29.93 Cr (+19% year on year). Net profit was ₹1.13 Cr (4% margin). EBITDA was ₹1.91 Cr (6% margin). Revenue has grown at a compounded annual rate of +38% over three years and +18% over five years.

  • ₹29.93 CrRevenue · FY 2024 · +19% YoY
  • ₹1.13 CrNet profit · 4% margin
  • ₹1.91 CrEBITDA · 6% margin
  • ₹2.31 CrPaid-up capital
  • 25Employees (provident fund records)
  • +38%Revenue CAGR, 3 years
  • +18%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Igenomix India Private Limited are on its company page.

Premium access

Detailed financial statements for Igenomix

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Igenomix

Igenomix has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Access Genomics.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Diagnostic tests for clinical genomic solutions are provided.
accessgenomics.caMississauga, Canada2016Dec 2020β€’β€’β€’β€’
Premium access

Complete acquisition details for Igenomix

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Igenomix

6 dated milestones of Igenomix across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded Igenomix is founded.
  2. Exit Acquired by Charme Capital Partners.
  3. Funding First funding round.
  4. Exit Acquired by EQT.
  5. Acquisition Acquires Access Genomics.
  6. Exit Acquired by Vitrolife.

Web traffic of Igenomix

The website of Igenomix (igenomix.com) receives about 17.9K visits a month.

  • Monthly visits
    17.9K

    ▲ 1.1% vs previous month

Similar websites

Websites whose visitors overlap most with Igenomix. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
myigenomix.com
myigenomix.com
100%
#1,403,098–
minifiv.es
minifiv.es
82%
#626,837–
creavalencia.com
creavalencia.com
80%
#1,220,202–
embarazoybebes.net
embarazoybebes.net
72%
–
natalben.com
72%
#165,008View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 10 similar websites and full traffic analytics for Igenomix

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 10 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Igenomix

Premium access

Complete news archive for Igenomix

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Igenomix

Igenomix was founded in 2009 and raised its 1st funding round 7 years after it was founded.

Igenomix is headquartered in Paterna, Spain. It is registered at Paterna, Valencian Community, Spain.

The primary company behind Igenomix, Igenomix India Private Limited, reported revenue of β‚Ή29.93 Cr for FY 2024, up 19% year on year.

Igenomix was founded in 2009 in Paterna, Spain, as a medical testing laboratory. Operations are conducted in the reproductive genetics sector, with genetic tests including PGT-A, ERA, and CGT offered to reproductive health professionals. Diagnosis and treatment of patients are supported through these services. A global presence is maintained, with activities spanning multiple countries.

Igenomix has made 1 acquisition, including Access Genomics.

Igenomix has 4 investors. Key investors include EQT, Vitrolife, Amadeus Capital Partners, and Charme Capital Partners.

Igenomix operates through Igenomix India Private Limited.

Yes. Igenomix was acquired by Vitrolife in July 2021.

The legal entities of Igenomix currently have 3 directors, including Deepak Khatter, Ricardo Manuel Capella Soriano, Francisco De Paula Ramon Rodriguez Herrera.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available